In an exclusive interview, Dr. Darren Ji (Vice President and Global Head of Roche Partnering, Asia and Emerging Markets) told ChinaBio® Today that Roche remains entirely focused on novel drugs for unmet needs. So it’s not surprising that the Swiss pharma is looking to partner with companies that have innovative drugs with unique differentiators, the potential to be either first-in-class or best-in-class (see story). Because China’s drug development scene is showing increasing levels of innovation, Dr. Ji says Roche works very hard to maintain relationships with China entrepreneurs. The company wants to bring innovative drugs to the “hugely important” China market, he adds, and it plans to bring novel China drugs to global markets.
Help employers find you! Check out all the jobs and post your resume.
